ENMAJU

Serial Number 90712401
734

Registration Progress

Application Filed
May 14, 2021
Under Examination
Apr 26, 2022
Approved for Publication
Mar 1, 2022
Published for Opposition
Mar 1, 2022
Registered

Trademark Image

ENMAJU

Basic Information

Serial Number
90712401
Filing Date
May 14, 2021
Published for Opposition
March 1, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Oct 25, 2024
Application
Pending
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle R. Weitzman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Oct 25, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 25, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 25, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 17, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 17, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 11, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 6, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 6, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 11, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 7, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 7, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 24, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 24, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 24, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 24, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 16, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 18, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005